Microbix Biosystems (TSE:MBX) Shares Pass Below 50 Day Moving Average – What’s Next?

Microbix Biosystems Inc. (TSE:MBX)’s share price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$0.24 and traded as low as C$0.24. Microbix Biosystems shares last traded at C$0.25, with a volume of 39,000 shares.

Microbix Biosystems Trading Up 4.3%

The stock has a market capitalization of C$34.01 million, a PE ratio of -15.31 and a beta of 0.03. The stock’s 50 day moving average price is C$0.24 and its 200-day moving average price is C$0.26. The company has a quick ratio of 5.57, a current ratio of 7.15 and a debt-to-equity ratio of 22.61.

Microbix Biosystems (TSE:MBX) last issued its earnings results on Thursday, December 18th. The company reported C($0.01) earnings per share for the quarter. The firm had revenue of C$3.74 million during the quarter. Microbix Biosystems had a return on equity of 12.65% and a net margin of 13.86%. On average, sell-side analysts expect that Microbix Biosystems Inc. will post 0.02 earnings per share for the current fiscal year.

About Microbix Biosystems

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.